Krystal Biotech, Inc. KRYS Net realized gains (losses)
Net realized gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s net realized gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s net realized gains (losses)?
- Krystal Biotech, Inc. (KRYS) reported net realized gains (losses) of $529K in Q1 2026.
- How has Krystal Biotech, Inc.'s net realized gains (losses) changed year-over-year?
- Krystal Biotech, Inc.'s net realized gains (losses) decreased by 64.8% year-over-year, from $1.5M to $529K.
- What does net realized gains (losses) mean?
- The cash profit or loss realized when selling investment securities.
- How do you interpret net realized gains (losses)?
- Positive values indicate successful investment management, while negative values suggest losses on liquidating assets.
- How does net realized gains (losses) compare across companies?
- Relevant for companies with active treasury management or significant investment portfolios.